Cargando…

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Llana, Helena, Panizo, Nayara, Gandía, Lorena, Orti, Marisa, Giménez-Civera, Elena, Forquet, Claudia, D’Marco, Luis, Puchades, Maria Jesús, Sargsyan, Mari, Sanchís, Irina, Ribera, Carmen, Marco, Mª Inés, Ferrá, Cristela Moncho, Pérez-Baylach, Carmen María, Bonilla, Begoña, Moncho Francés, Francesc, Perez-Bernat, Elisa, Sancho, Asunción, Górriz, Jose Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878467/
https://www.ncbi.nlm.nih.gov/pubmed/35214757
http://dx.doi.org/10.3390/vaccines10020299
_version_ 1784658667239374848
author Garcia-Llana, Helena
Panizo, Nayara
Gandía, Lorena
Orti, Marisa
Giménez-Civera, Elena
Forquet, Claudia
D’Marco, Luis
Puchades, Maria Jesús
Sargsyan, Mari
Sanchís, Irina
Ribera, Carmen
Marco, Mª Inés
Ferrá, Cristela Moncho
Pérez-Baylach, Carmen María
Bonilla, Begoña
Moncho Francés, Francesc
Perez-Bernat, Elisa
Sancho, Asunción
Górriz, Jose Luis
author_facet Garcia-Llana, Helena
Panizo, Nayara
Gandía, Lorena
Orti, Marisa
Giménez-Civera, Elena
Forquet, Claudia
D’Marco, Luis
Puchades, Maria Jesús
Sargsyan, Mari
Sanchís, Irina
Ribera, Carmen
Marco, Mª Inés
Ferrá, Cristela Moncho
Pérez-Baylach, Carmen María
Bonilla, Begoña
Moncho Francés, Francesc
Perez-Bernat, Elisa
Sancho, Asunción
Górriz, Jose Luis
author_sort Garcia-Llana, Helena
collection PubMed
description The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.
format Online
Article
Text
id pubmed-8878467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88784672022-02-26 COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study Garcia-Llana, Helena Panizo, Nayara Gandía, Lorena Orti, Marisa Giménez-Civera, Elena Forquet, Claudia D’Marco, Luis Puchades, Maria Jesús Sargsyan, Mari Sanchís, Irina Ribera, Carmen Marco, Mª Inés Ferrá, Cristela Moncho Pérez-Baylach, Carmen María Bonilla, Begoña Moncho Francés, Francesc Perez-Bernat, Elisa Sancho, Asunción Górriz, Jose Luis Vaccines (Basel) Article The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact. MDPI 2022-02-16 /pmc/articles/PMC8878467/ /pubmed/35214757 http://dx.doi.org/10.3390/vaccines10020299 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Garcia-Llana, Helena
Panizo, Nayara
Gandía, Lorena
Orti, Marisa
Giménez-Civera, Elena
Forquet, Claudia
D’Marco, Luis
Puchades, Maria Jesús
Sargsyan, Mari
Sanchís, Irina
Ribera, Carmen
Marco, Mª Inés
Ferrá, Cristela Moncho
Pérez-Baylach, Carmen María
Bonilla, Begoña
Moncho Francés, Francesc
Perez-Bernat, Elisa
Sancho, Asunción
Górriz, Jose Luis
COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title_full COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title_fullStr COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title_full_unstemmed COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title_short COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
title_sort covid-19 vaccination improved psychological distress (anxiety and depression scores) in chronic kidney disease patients: a prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878467/
https://www.ncbi.nlm.nih.gov/pubmed/35214757
http://dx.doi.org/10.3390/vaccines10020299
work_keys_str_mv AT garciallanahelena covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT panizonayara covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT gandialorena covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT ortimarisa covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT gimenezciveraelena covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT forquetclaudia covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT dmarcoluis covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT puchadesmariajesus covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT sargsyanmari covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT sanchisirina covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT riberacarmen covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT marcomaines covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT ferracristelamoncho covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT perezbaylachcarmenmaria covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT bonillabegona covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT monchofrancesfrancesc covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT perezbernatelisa covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT sanchoasuncion covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy
AT gorrizjoseluis covid19vaccinationimprovedpsychologicaldistressanxietyanddepressionscoresinchronickidneydiseasepatientsaprospectivestudy